NO164416C - Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. - Google Patents

Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.

Info

Publication number
NO164416C
NO164416C NO841690A NO841690A NO164416C NO 164416 C NO164416 C NO 164416C NO 841690 A NO841690 A NO 841690A NO 841690 A NO841690 A NO 841690A NO 164416 C NO164416 C NO 164416C
Authority
NO
Norway
Prior art keywords
pyridinones
acyl
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO841690A
Other languages
English (en)
Other versions
NO841690L (no
NO164416B (no
Inventor
Winton D Jones
Richard A Schnettler
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO841690L publication Critical patent/NO841690L/no
Publication of NO164416B publication Critical patent/NO164416B/no
Publication of NO164416C publication Critical patent/NO164416C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO841690A 1983-04-29 1984-04-27 Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. NO164416C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/490,081 US4568751A (en) 1983-04-29 1983-04-29 5-Acyl-2-(1H)-pyridinones

Publications (3)

Publication Number Publication Date
NO841690L NO841690L (no) 1984-10-30
NO164416B NO164416B (no) 1990-06-25
NO164416C true NO164416C (no) 1990-10-03

Family

ID=23946554

Family Applications (2)

Application Number Title Priority Date Filing Date
NO841690A NO164416C (no) 1983-04-29 1984-04-27 Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO841691A NO164415C (no) 1983-04-29 1984-04-27 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO841691A NO164415C (no) 1983-04-29 1984-04-27 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.

Country Status (22)

Country Link
US (1) US4568751A (no)
EP (2) EP0124089B1 (no)
JP (2) JPS59206356A (no)
KR (2) KR900005010B1 (no)
AR (1) AR240313A1 (no)
AT (2) ATE25678T1 (no)
AU (2) AU557543B2 (no)
CA (2) CA1242443A (no)
DD (1) DD223444A5 (no)
DE (2) DE3462503D1 (no)
DK (2) DK159425C (no)
ES (2) ES8505955A1 (no)
GR (2) GR81967B (no)
HU (2) HU191753B (no)
IE (2) IE57285B1 (no)
IL (2) IL71649A (no)
NO (2) NO164416C (no)
NZ (2) NZ207960A (no)
PH (1) PH20256A (no)
PT (2) PT78493B (no)
SU (1) SU1299505A3 (no)
ZA (2) ZA843034B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118696A (en) * 1983-04-29 1992-06-02 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones useful for treating cardiac failure
US4731371A (en) * 1984-03-29 1988-03-15 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-1,2-dihydro-2-oxo-3-pyridinecarbonitriles which are useful as cardiotonic agents
US4992452A (en) * 1983-04-29 1991-02-12 Merrell Dow Pharmaceuticals Inc. Certain 5-acyl-2-(1H)-pyridinones useful in treating cardiac failure
US5428045A (en) * 1983-04-29 1995-06-27 Merrell Dow Pharmaceuticals Inc. 5-acyl-2-(1H)-pyridinoes
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
US4853395A (en) * 1983-04-29 1989-08-01 Merrell Dow Pharmaceuticals Inc. Certain 3-carboxylate or 3-carbamyl-5-acyl-2-(1H)-pyridinones having cardiotonic properties
US4732982A (en) * 1983-11-03 1988-03-22 Merrell Dow Pharmaceuticals Inc. Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
US4657919A (en) * 1984-08-03 1987-04-14 E. I. Du Pont De Nemours & Co. Pyridone esters as inotropic agents
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2531035A1 (de) * 1975-07-11 1977-01-27 Basf Ag Verfahren zur herstellung von 5-cyanpyridonen-(6)
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones
GB1596887A (en) * 1977-07-15 1981-09-03 Rohm & Haas 2-pyridone derivatives and their use as plant growth regulators
DE3005069A1 (de) * 1980-02-11 1981-08-20 Cassella Ag, 6000 Frankfurt Pyridonderivate, ihre herstellung und ihre verwendung
DE3106460A1 (de) * 1980-03-03 1982-01-28 Sandoz-Patent-GmbH, 7850 Lörrach 2(1h)-pyridinon-derivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
US4412077A (en) * 1982-03-15 1983-10-25 Sterling Drug Inc. Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
US4524149A (en) * 1982-03-15 1985-06-18 Sterling Drug Inc. 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use
US4568751A (en) * 1983-04-29 1986-02-04 Merrell Dow Pharmaceuticals Inc. 5-Acyl-2-(1H)-pyridinones
DE3406329A1 (de) * 1984-02-22 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt Pyridone

Also Published As

Publication number Publication date
NO164415B (no) 1990-06-25
JPS59206355A (ja) 1984-11-22
IL71649A (en) 1987-10-30
HU191928B (en) 1987-04-28
NO841691L (no) 1984-10-30
DD223444A5 (de) 1985-06-12
IE841047L (en) 1984-10-29
AU571219B2 (en) 1988-04-14
EP0124090B1 (en) 1987-04-01
NZ207960A (en) 1987-05-29
GR81967B (no) 1984-12-12
AU557543B2 (en) 1986-12-24
DK213584D0 (da) 1984-04-27
IL71648A0 (en) 1984-07-31
KR900005011B1 (ko) 1990-07-16
DK159425C (da) 1991-03-18
PT78493B (en) 1986-05-20
IE841046L (en) 1984-10-29
NO164415C (no) 1990-10-03
DK213284D0 (da) 1984-04-27
IL71648A (en) 1987-11-30
DK159425B (da) 1990-10-15
NO841690L (no) 1984-10-30
EP0124089A1 (en) 1984-11-07
JPH0579668B2 (no) 1993-11-04
KR840008323A (ko) 1984-12-14
ATE26262T1 (de) 1987-04-15
GR81990B (no) 1984-12-12
US4568751A (en) 1986-02-04
PT78493A (en) 1984-05-01
DK159424C (da) 1991-03-18
ZA843033B (en) 1984-11-28
EP0124089B1 (en) 1987-03-04
KR900005010B1 (ko) 1990-07-16
IE57273B1 (en) 1992-07-01
ES531911A0 (es) 1985-06-01
ES531910A0 (es) 1985-06-01
EP0124090A1 (en) 1984-11-07
DK213284A (da) 1984-10-30
AR240313A1 (es) 1990-03-30
DE3462503D1 (en) 1987-04-09
NO164416B (no) 1990-06-25
JPS59206356A (ja) 1984-11-22
DE3462889D1 (de) 1987-05-07
CA1242443A (en) 1988-09-27
CA1256880A (en) 1989-07-04
ES8505956A1 (es) 1985-06-01
NZ207961A (en) 1986-09-10
HUT34007A (en) 1985-01-28
PT78491B (en) 1986-05-22
IE57285B1 (en) 1992-07-15
SU1299505A3 (ru) 1987-03-23
DK159424B (da) 1990-10-15
PH20256A (en) 1986-11-14
ES8505955A1 (es) 1985-06-01
HUT34006A (en) 1985-01-28
KR840008322A (ko) 1984-12-14
JPH058192B2 (no) 1993-02-01
PT78491A (en) 1984-05-01
DK213584A (da) 1984-10-30
AU2713184A (en) 1984-11-01
ZA843034B (en) 1984-11-28
HU191753B (en) 1987-04-28
IL71649A0 (en) 1984-07-31
AU2714184A (en) 1984-11-01
ATE25678T1 (de) 1987-03-15

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
NO163691C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO158534C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksyalkylkarboksylsyrederivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO164416C (no) Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO161800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-aryl-2-halo-1-etenyl)-1h-azoler.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO163529C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner.